Researchers are analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr Virus, or EBV
Through the technology—modeling a human heart on an engineered chip and measuring the effects of compound exposure on functions of heart tissue using microelectrodes—researchers hope to decrease the time needed for new drug trials